Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD

医学 失代偿 队列 门静脉压 内科学 门脉高压 队列研究 危险分层 慢性肝病 肝病 胃肠病学 肝硬化 肝功能不全 多元分析 试验预测值 肝脏疾病 血压 疾病 风险因素 回顾性队列研究 前瞻性队列研究 外科 风险评估 脂肪变性
作者
Mathias Jachs,Paul Thöne,Aitor Odriozola,Fanny Turón,Lucile Moga,Luís Téllez,Petra Fischer,Dario Saltini,Wilhelmus J. Kwanten,Maria Grasso,Elba Llop,Yuly P. Mendoza,Angelo Armandi,Carlos A. Pardo,Antonio Colecchia,Federico Ravaioli,Benjamin Maasoumy,Wim Laleman,José Presa,Jörn M. Schattenberg
出处
期刊:Journal of Hepatology [Elsevier BV]
卷期号:84 (4): 738-748 被引量:5
标识
DOI:10.1016/j.jhep.2025.10.019
摘要

BACKGROUND & AIMS: The NICER (liver and spleen stiffness by vibration-controlled transient elastography, platelet count, and BMI) and the ANTICIPATE±NASH models predict clinically significant portal hypertension (CSPH) in compensated advanced chronic liver disease (cACLD). This study reports follow-up data from the NICER cohort, comparing the prognostic utility of non-invasive tests for CSPH (CSPH-NITs) and hepatic venous pressure gradient (HVPG). METHODS: Patients with Child-Turcotte-Pugh A cACLD (liver stiffness ≥10 kPa and/or F3/4) from 16 European centres undergoing paired HVPG and CSPH-NIT assessment between 2020-2023 were included and followed until incident hepatic decompensation, hepatocellular carcinoma, death, or last visit. RESULTS: Three hundred and fifty-eight patients with cACLD were included (MASLD: 40.7%; MetALD/ALD: 32.1%; viral: 16.2%), with a CSPH prevalence of 62.0%. The cumulative 1-year and 2-year incidences of decompensation were 7.3 (95% CI 5.9-8.7%) and 12.6 (10.3-14.9%). Albumin levels were a key predictor of decompensation (subdistribution hazard ratio [sHR] 0.836; 95% CI 0.779-0.897), alongside HVPG (albumin-adjusted SHR 1.126; 95% CI 1.059-1.198), NICER (albumin-adjusted SHR 1.207; 95% CI 1.043-1.397), or ANTICIPATE±NASH (albumin-adjusted SHR 1.174; 95% CI 1.003-1.374). Models incorporating albumin alongside HVPG or CSPH-NIT achieved high C-indices for decompensation (0.772-0.806). Stratifying patients by a predicted 1-year decompensation-free survival probability of ≥95% or <95% identified approximately 60% of patients as being at negligible 1-year risk (1.4-2.1%), while the remaining patients were at high risk of decompensation (14.3-16.0%). CONCLUSION: In our multicentre study of contemporary European patients with cACLD, non-invasively estimated CSPH risk was as predictive for decompensation as HVPG. Models comprising indicators of portal hypertension and albumin discriminated between patients at negligible decompensation risk and those with a 1-year risk of approximately 15%, i.e. the potential target population for preventive strategies. IMPACT AND IMPLICATIONS: Non-invasive tests (NITs) facilitate the early diagnosis and management of clinically significant portal hypertension in patients with compensated advanced chronic liver disease (cACLD). In our contemporary cohort of patients with cACLD, mainly steatotic liver disease, recruited at 16 European expert centres, the hepatic venous pressure gradient and NITs were similarly predictive of decompensation within 1 to 2 years of follow-up. Serum albumin levels were identified as the second main predictor of decompensation after hepatic venous pressure gradient or NITs for clinically significant portal hypertension. Novel models were developed that could accurately predict the risk of decompensation, thereby refining point-of-care risk stratification and informing clinical trial design for patients with CTP-A cACLD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YOUNG-M完成签到,获得积分10
刚刚
lucaslucas完成签到 ,获得积分10
刚刚
delusionY完成签到 ,获得积分10
1秒前
Saber完成签到,获得积分10
1秒前
完美世界的应助被alandan采纳,获得10
1秒前
Cecilia完成签到,获得积分10
2秒前
尘有心完成签到 ,获得积分10
2秒前
爆米花的应助被liangchao采纳,获得50
2秒前
科研通AI6.2的应助被liangchao采纳,获得50
2秒前
科研通AI6.2的应助被liangchao采纳,获得50
2秒前
光亮向真发布了新的文献求助10
3秒前
6秒前
6秒前
6秒前
7秒前
姜糊完成签到 ,获得积分10
7秒前
yishu完成签到,获得积分20
8秒前
缺粥发布了新的文献求助10
9秒前
北冰洋的繇鱼完成签到,获得积分10
9秒前
yulihh完成签到,获得积分10
9秒前
9秒前
啊啊啊啊啊啊啊完成签到,获得积分10
10秒前
杨子墨发布了新的文献求助10
10秒前
Hh完成签到,获得积分10
11秒前
ffffwj2024完成签到,获得积分10
11秒前
研友_X89o6n完成签到,获得积分10
11秒前
小王发布了新的文献求助10
11秒前
生动的乐曲完成签到,获得积分10
11秒前
12秒前
生动的访琴完成签到,获得积分10
12秒前
r12r1完成签到,获得积分10
13秒前
姜姜完成签到,获得积分10
13秒前
throb发布了新的文献求助10
13秒前
零零1完成签到 ,获得积分10
14秒前
碎觉觉发布了新的文献求助10
15秒前
16秒前
16秒前
16秒前
Nuyoah完成签到 ,获得积分10
17秒前
转复窦律完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190478
求助须知:如何正确求助?哪些是违规求助? 9577686
关于积分的说明 21853808
捐赠科研通 7789496
什么是DOI,文献DOI怎么找? 3436407
关于科研通互助平台的介绍 2560235
邀请新用户注册赠送积分活动 2483054